subject: Aarkstore Enterprise -- Allergic Rhinitis - Pipeline Assessment And Market Forecasts To 2017 [print this page] Aarkstore announce a new report "Allergic Rhinitis - Pipeline Assessment and Market Forecasts to 2017" through its vast collection of market research report.
Allergic Rhinitis - Pipeline Assessment and Market Forecasts to 2017
Summary
The industry analysis specialist, has released a new report, Allergic Rhinitis - Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global allergic rhinitis market. The report identifies the key trends shaping and driving the global allergic rhinitis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to significantly shift the market positioning of the existing market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global allergic rhinitis sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis team of industry experts.
Scope
The report provides information on the key drivers and challenges of the global allergic rhinitis market. Its scope includes:
- Annualized global allergic rhinitis market revenues data from 2001 to 2009, forecast for eight years to 2017.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. The key mechanisms of action include histamine antagonists, anti-inflammatory agents, corticosteroids and immunomodulators.
- Analysis of the current and future market competition in the global allergic rhinitis market. The key market players covered are Merck & Co, GlaxoSmithKline, AstraZeneca, Novartis AG, Sanofi-Aventis and HAL Allergy.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include a strategic competitor assessment, market characterization, unmet needs and the implications for the allergic rhinitis therapeutics market.
